Randomized phase II trial of zolbetuximab as second-line treatment in patients with claudin 18.2-positive advanced gastric/GEJ cancer with previous zolbetuximab exposure: ZELDA.

albumin-bound paclitaxel - Generic mfg.

Vyloy (zolbetuximab-clzb) - Astellas

Cyramza (ramucirumab) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42756594

C Inagaki; E Oki; H Hirano; H Kawakami; K Ando; K Muro; K Murotani; M Furuta; T Esaki; Y Narita

Sep 19, 2026